News for 'life-sciences'

Lupin acquires US generics firm GAVIS for $880 mn

Lupin acquires US generics firm GAVIS for $880 mn

Rediff.com24 Jul 2015

Lupin will fund the buy through $100 mn cash reserves and a bridge loan.

Sensex ends below 27,000; ITC, ICICI Bank dip 2%

Sensex ends below 27,000; ITC, ICICI Bank dip 2%

Rediff.com7 Jan 2015

The 30-share Sensex ended 79 points lower at 26,909 and the 50-share Nifty closed 25 points lower at 8,102.

Nandini Piramal gallops away in the OTC business

Nandini Piramal gallops away in the OTC business

Rediff.com13 Jul 2017

'Younger people are taking steps to prevent lifestyle diseases.'
'It is fascinating to partner with consumers on the journey of self-discovery and to help shape people's preferences -- that is what I find most exciting,' Nandini Piramal tells Abhineet Kumar and Aneesh Phadnis.

Pharma cos should learn to appreciate FDA norms: Experts

Pharma cos should learn to appreciate FDA norms: Experts

Rediff.com23 Nov 2014

Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations

Sensex ends above 27,200 led by ITC

Sensex ends above 27,200 led by ITC

Rediff.com22 Sep 2014

Tata Motors, ONGC, HDFC and TCS were the top gainers.

This Indian school hopes to solve the world's problems

This Indian school hopes to solve the world's problems

Rediff.com8 May 2018

A group of high-powered individuals led by Anand Mahindra have come together to set up Krea university. The campus is expected to be ready by 2019 and the first batch of 100 to 125 students will commence classes in August next year.

'Which university should I opt for?'

'Which university should I opt for?'

Rediff.com13 Mar 2015

In an online chat with readers overseas education consultant NNS Chandra addressed queries related to international admissions.

Band, bajaa and masti: Indians celebrate Independence Day in New York

Band, bajaa and masti: Indians celebrate Independence Day in New York

Rediff.com22 Aug 2016

The 36th India Day Parade ran through about 13 streets in Madison avenue in Manhattan.

Wipro Q1 profit rises 29.5% to Rs 2,103 cr

Wipro Q1 profit rises 29.5% to Rs 2,103 cr

Rediff.com24 Jul 2014

The Bangalore-headquartered firm had posted a net profit of Rs 1,623.3 crore (Rs 16.23 billion) in the year-ago period, it said in a BSE filing.

'Gross hiring by TCS will go down for FY17'

'Gross hiring by TCS will go down for FY17'

Rediff.com20 Apr 2016

'We are at a time and position that we do not need higher number of visas.'

US drug regulator finds Indian companies critically ill

US drug regulator finds Indian companies critically ill

Rediff.com24 Sep 2013

The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.

Markets end flat amid volatile trade

Markets end flat amid volatile trade

Rediff.com3 Nov 2014

Custodian banks are selling dollars for their foreign fund clients.

Fulfilling Deveshwar's dreams: A big challenge for ITC's new chief

Fulfilling Deveshwar's dreams: A big challenge for ITC's new chief

Rediff.com19 Aug 2016

The outgoing chairman believed in building for the future; for his successor, the challenge will be to maintain the momentum, says Ishita Ayan Dutt.

Sensex jumps 263 points after Ukraine fears recede

Sensex jumps 263 points after Ukraine fears recede

Rediff.com4 Mar 2014

Markets rebound with financials leading the gains on hopes of a peaceful solution to the turmoil in Ukraine

It's still a man's world, women sidelined in India Inc

It's still a man's world, women sidelined in India Inc

Rediff.com4 Sep 2015

When it comes to key hands-on management positions, India Inc is still largely run by men.

US think tank seeks suspension of trade policies with India

US think tank seeks suspension of trade policies with India

Rediff.com15 May 2013

From Lalit K Jha Washington, May 15 (PTI) Alleging that recent trade policies of India are jeopardising its trade ties with the US, a Washington-based think tank has recommended the Congress to suspend trade benefits for New Delhi. "To be clear, a strong, growing, and collaborative trade relationshi ...

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

Markets end flat amid rangebound trade; Midcaps outperform

Markets end flat amid rangebound trade; Midcaps outperform

Rediff.com29 Dec 2015

BSE Midcap index outperformed the benchmark indices to end with 0.4% gains.

Hurrah! Indian students can work in UK post studies

Hurrah! Indian students can work in UK post studies

Rediff.com14 Dec 2015

Indians are welcome to study and work in Great Britain, says UK's Minister for Science and Universities Jo Johnson.

IT firms widen base with big data

IT firms widen base with big data

Rediff.com13 Sep 2013

Amid subdued demand for traditional information technology (IT) services offerings, Indian IT services players are betting on big data, as this is high on clients' agenda.

India acts to repair reputation as drugs exporter

India acts to repair reputation as drugs exporter

Rediff.com7 May 2014

As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.

ITC follows the Aashirvaad trail

ITC follows the Aashirvaad trail

Rediff.com28 Dec 2015

Today Aashirvaad, ITC says, has 75 per cent of the market.

Tech Mahindra's journey with Satyam so far

Tech Mahindra's journey with Satyam so far

Rediff.com10 Apr 2015

After taking over scam-hit Satyam, Techn Mahindra has made many structural changes in the latter to turn it around.

AstraZeneca rejects Pfizer's final deal offer

AstraZeneca rejects Pfizer's final deal offer

Rediff.com19 May 2014

Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer , casting serious doubt on the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals group.

Sensex ends at 27,098 ahead of F&O expiry, Fed meet outcome

Sensex ends at 27,098 ahead of F&O expiry, Fed meet outcome

Rediff.com29 Oct 2014

US stocks rose more than 1% on Tuesday, with the S&P 500 coming less than 2% below its record peak set last month.

Markets end higher; Sep inflation, RIL Q2 eyed

Markets end higher; Sep inflation, RIL Q2 eyed

Rediff.com13 Oct 2014

Markets recovered in late trades, amid firm European cues, led by rebound in financials and gains in IT shares.

Wipro earnings meet expectations

Wipro earnings meet expectations

Rediff.com18 Jan 2014

The company's net profit went up 27% in December quarter, sequentially better than peers; core IT services up 33%..

Is the Maggi saga stifling food companies?

Is the Maggi saga stifling food companies?

Rediff.com31 Jul 2015

The future too looks grim.

Sensex ends in the red amid volatile trade; IT, auto, realty fall

Sensex ends in the red amid volatile trade; IT, auto, realty fall

Rediff.com24 Mar 2015

The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.

India Shining! Precious forest land wiped away for 23,716 industrial projects

India Shining! Precious forest land wiped away for 23,716 industrial projects

Rediff.com3 Jun 2016

The government may claim planted trees compensate for forests lost, but that does not mean complex flora and fauna destroyed have been restored, points out Himadri Ghosh.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Likely Nobel prize winners for 2014

Likely Nobel prize winners for 2014

Rediff.com25 Sep 2013

The IP & Science business of Thomson Reuters has announced its 2013 "Nobel-class" Citation Laureates on Wednesday, which names 28 researchers representing 22 distinct academic and research organisations, and six different countries.

Is cancer just bad luck?

Is cancer just bad luck?

Rediff.com17 Jan 2015

A recent study, which says two-thirds of cancers are a result of random mutations, also makes a case for the prevention, early detection and treatment of the disease

What Nandan plans to do at Infosys

What Nandan plans to do at Infosys

Rediff.com26 Aug 2017

New strategy for Infosys by October, says Nandan Nilekani. New chairman's other priorities: Hiring CEO, reviewing Panaya probe reports.

Markets decline on caution ahead of the Union Budget

Markets decline on caution ahead of the Union Budget

Rediff.com9 Jul 2014

The market breadth ended weak on the BSE with 2,086 shares declining and 893 shares advancing.

Bird-watch your way through Delhi's feather trail

Bird-watch your way through Delhi's feather trail

Rediff.com16 Mar 2015

The urban jungle still retains some precious wild spaces inhabited by not frequently seen birds and animals. The author spends a day exploring them

What's behind Bharat Biotech's Zika 'hype'?

What's behind Bharat Biotech's Zika 'hype'?

Rediff.com16 Feb 2016

Bharat Biotech started work on developing a vaccine against Zika way back in 2014.

Why Larry and Sergey named Sundar Google CEO

Why Larry and Sergey named Sundar Google CEO

Rediff.com11 Aug 2015

'Sergey and I have been super excited about his progress and dedication to the company. And it is clear to us and our board that it is time for Sundar to be CEO of Google,' Lary Page said.

Infosys on a roll in Q3

Infosys on a roll in Q3

Rediff.com10 Jan 2015

Infosys is likely to put up a good show.

'We need to solve Indian problems the Indian way'

'We need to solve Indian problems the Indian way'

Rediff.com12 Jan 2016

'Science and technology keep moving ahead and so you can keep making investment.'